table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Oncology Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Oncology Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Oncology Testing Overall Market Size
2.1 Global Cancer Oncology Testing Market Size: 2023 VS 2030
2.2 Global Cancer Oncology Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Oncology Testing Players in Global Market
3.2 Top Global Cancer Oncology Testing Companies Ranked by Revenue
3.3 Global Cancer Oncology Testing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Oncology Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Oncology Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Oncology Testing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Oncology Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Oncology Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Oncology Testing Market Size Markets, 2023 & 2030
4.1.2 Fluorescence In Situ Hybridization
4.1.3 Polymerase Chain Reaction
4.1.4 Microarray Technology
4.1.5 Serum Proteomics
4.1.6 Nucleic Acid Sequencing
4.2 By Type - Global Cancer Oncology Testing Revenue & Forecasts
4.2.1 By Type - Global Cancer Oncology Testing Revenue, 2019-2024
4.2.2 By Type - Global Cancer Oncology Testing Revenue, 2025-2030
4.2.3 By Type - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Oncology Testing Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.1.4 Research Institutes
5.1.5 Diagnostics Laboratories
5.1.6 Biopharmaceutical Companies
5.2 By Application - Global Cancer Oncology Testing Revenue & Forecasts
5.2.1 By Application - Global Cancer Oncology Testing Revenue, 2019-2024
5.2.2 By Application - Global Cancer Oncology Testing Revenue, 2025-2030
5.2.3 By Application - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Oncology Testing Market Size, 2023 & 2030
6.2 By Region - Global Cancer Oncology Testing Revenue & Forecasts
6.2.1 By Region - Global Cancer Oncology Testing Revenue, 2019-2024
6.2.2 By Region - Global Cancer Oncology Testing Revenue, 2025-2030
6.2.3 By Region - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Oncology Testing Revenue, 2019-2030
6.3.2 US Cancer Oncology Testing Market Size, 2019-2030
6.3.3 Canada Cancer Oncology Testing Market Size, 2019-2030
6.3.4 Mexico Cancer Oncology Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Oncology Testing Revenue, 2019-2030
6.4.2 Germany Cancer Oncology Testing Market Size, 2019-2030
6.4.3 France Cancer Oncology Testing Market Size, 2019-2030
6.4.4 U.K. Cancer Oncology Testing Market Size, 2019-2030
6.4.5 Italy Cancer Oncology Testing Market Size, 2019-2030
6.4.6 Russia Cancer Oncology Testing Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Oncology Testing Market Size, 2019-2030
6.4.8 Benelux Cancer Oncology Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Oncology Testing Revenue, 2019-2030
6.5.2 China Cancer Oncology Testing Market Size, 2019-2030
6.5.3 Japan Cancer Oncology Testing Market Size, 2019-2030
6.5.4 South Korea Cancer Oncology Testing Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Oncology Testing Market Size, 2019-2030
6.5.6 India Cancer Oncology Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Oncology Testing Revenue, 2019-2030
6.6.2 Brazil Cancer Oncology Testing Market Size, 2019-2030
6.6.3 Argentina Cancer Oncology Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Oncology Testing Revenue, 2019-2030
6.7.2 Turkey Cancer Oncology Testing Market Size, 2019-2030
6.7.3 Israel Cancer Oncology Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Oncology Testing Market Size, 2019-2030
6.7.5 UAE Cancer Oncology Testing Market Size, 2019-2030
7 Cancer Oncology Testing Companies Profiles
7.1 Devyser
7.1.1 Devyser Company Summary
7.1.2 Devyser Business Overview
7.1.3 Devyser Cancer Oncology Testing Major Product Offerings
7.1.4 Devyser Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.1.5 Devyser Key News & Latest Developments
7.2 Agendia
7.2.1 Agendia Company Summary
7.2.2 Agendia Business Overview
7.2.3 Agendia Cancer Oncology Testing Major Product Offerings
7.2.4 Agendia Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.2.5 Agendia Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Cancer Oncology Testing Major Product Offerings
7.3.4 Illumina Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.3.5 Illumina Key News & Latest Developments
7.4 Personal Genome Diagnostics
7.4.1 Personal Genome Diagnostics Company Summary
7.4.2 Personal Genome Diagnostics Business Overview
7.4.3 Personal Genome Diagnostics Cancer Oncology Testing Major Product Offerings
7.4.4 Personal Genome Diagnostics Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.4.5 Personal Genome Diagnostics Key News & Latest Developments
7.5 Veracyte
7.5.1 Veracyte Company Summary
7.5.2 Veracyte Business Overview
7.5.3 Veracyte Cancer Oncology Testing Major Product Offerings
7.5.4 Veracyte Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.5.5 Veracyte Key News & Latest Developments
7.6 Pacific Biosciences of California
7.6.1 Pacific Biosciences of California Company Summary
7.6.2 Pacific Biosciences of California Business Overview
7.6.3 Pacific Biosciences of California Cancer Oncology Testing Major Product Offerings
7.6.4 Pacific Biosciences of California Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.6.5 Pacific Biosciences of California Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Cancer Oncology Testing Major Product Offerings
7.7.4 Qiagen Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.7.5 Qiagen Key News & Latest Developments
7.8 Agilent Technologies
7.8.1 Agilent Technologies Company Summary
7.8.2 Agilent Technologies Business Overview
7.8.3 Agilent Technologies Cancer Oncology Testing Major Product Offerings
7.8.4 Agilent Technologies Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.8.5 Agilent Technologies Key News & Latest Developments
7.9 Natera
7.9.1 Natera Company Summary
7.9.2 Natera Business Overview
7.9.3 Natera Cancer Oncology Testing Major Product Offerings
7.9.4 Natera Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.9.5 Natera Key News & Latest Developments
7.10 Bio Rad Laboratories
7.10.1 Bio Rad Laboratories Company Summary
7.10.2 Bio Rad Laboratories Business Overview
7.10.3 Bio Rad Laboratories Cancer Oncology Testing Major Product Offerings
7.10.4 Bio Rad Laboratories Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.10.5 Bio Rad Laboratories Key News & Latest Developments
7.11 Myriad Genetics
7.11.1 Myriad Genetics Company Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Cancer Oncology Testing Major Product Offerings
7.11.4 Myriad Genetics Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.11.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
